MARKET

CLGN

CLGN

Collplant Biotechnologies Ltd
NASDAQ
0.6237
-0.0363
-5.50%
After Hours: 0.6011 -0.0226 -3.62% 19:55 03/27 EDT
OPEN
0.7100
PREV CLOSE
0.6600
HIGH
0.7100
LOW
0.6000
VOLUME
31.99K
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
0.4950
MARKET CAP
7.99M
P/E (TTM)
-0.6103
1D
5D
1M
3M
1Y
5Y
1D
CollPlant Biotechnologies Details 2025 Results, Bioprinting Launch and Regenerative Implant Progress
TipRanks · 2d ago
CollPlant Biotechnologies Non-GAAP EPS of -$0.83, revenue of $2.37M
Seeking Alpha · 2d ago
CollPlant Biotechnologies Q4 Adj. EPS $(0.25) Misses $(0.19) Estimate, Sales $60.000K Miss $1.524M Estimate.
Benzinga · 2d ago
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
PR Newswire · 2d ago
Earnings Scheduled For March 26, 2026
Benzinga · 2d ago
CollPlant Biotechnologies Faces Nasdaq Bid-Price Deficiency, Granted Compliance Window
TipRanks · 3d ago
CollPlant receives Nasdaq notice over minimum $1 bid price
Seeking Alpha · 3d ago
CollPlant receives non-compliance letter from Nasdaq
TipRanks · 3d ago
More
About CLGN
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Webull offers Collplant Biotechnologies Ltd - ADR stock information, including NASDAQ: CLGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLGN stock methods without spending real money on the virtual paper trading platform.